SOLBIOTE™ - Bringing Sustainable Solutions to Biopharmaceuticals

SOLBIOTE™ - Bringing Sustainable Solutions to Biopharmaceuticals

Nagase Viita Co., Ltd. , the first company in the world to mass produce Trehalose, offers solutions for biopharmaceutical development through our signature brand of SOLBIOTE™. It features high-purity, low-endotoxin Trehalose (TREHALOSE SG) and Maltose (MALTOSE PH) saccharide-based pharmaceutical excipients. We confidently offer a stable supply of SOLBIOTE™ as an integrated manufacturer of the Trehalose and Maltose, guaranteeing exceptional quality.


Stability solutions

  • SOLBIOTE™ is an excellent protein stabilizer
  • Protects cells, nucleotides, and exosomes against damage from drying, freezing, and thawing
  • Preserves the quality of antibody therapeutics and vaccines during storage and distribution

Exceptional quality

  • High-purity and low-endotoxin
  • Complies with the global regulatory requirements of the pharmaceutical industry
  • Achieve superior quality with our extensive knowledge and expertise in saccharide production


Portfolio


Sustainable manufacturing and stable supply

  • Utilize starch and enzymes derived from soil microorganisms
  • Trehalose dihydrate crystalline and Maltose monohydrate crystalline are highly purified with a low endotoxin specification
  • No solvents listed in ICH Q3C Class 1, 2 or 3 are used through manufacturing processes
  • Our integrated manufacturing process ensures exceptional quality control and a stable supply by overseeing the procurement of raw materials, to saccharide production and purification in our factory in Japan.

More information about Nagase Viita and SOLBIOTE™

To view or add a comment, sign in

More articles by PharmaExcipients.com

Explore topics